<p>(A) MAPK p38 and NF-κB p65 expression levels detected by western blotting. (B) Semi-quantitative analysis of the NF-κB levels detected by western blotting. (C) Semi-quantitative analysis of the MAPK p38 levels detected by western blotting. Different symbols indicate statistical significance (<i>p</i><0.05).</p
<p>(<b>A</b>) Expression of different angiogenic factors (left panel) in the vehicle- and PTK787 tre...
<p>A,.Western blotting of Bax and Bcl-2 in the mitochondrial fraction and cytosolic fraction of NRK-...
Western blot analyses showing quantification of phosphorylated levels of p38 and ERK1/2. Total level...
<p>(A) Negative control and the immunocytochemical staining of EL at 0 h, 4 h, 8 h, 12 h and 24 h af...
<p>Panel A: The p38<sup>MAPK</sup> inhibitor SB203580 (10 µM) reversed the antiproliferative effect ...
<p>A. The cells were incubated with 0, 10, 50, 250, and 1000 ng/ml Ang for 2 h. The proteins of phos...
<p>AngII treatment was shown to promote HUVEC proliferation by immunofluorescence staining of PCNA a...
<p>(A) Representative Western blotting results, showing bands for phosphorylated ERK1/2 (p-ERK1/2) a...
<p>(A) rhGM-CSF induced activation of the p38 MAPK signaling pathway. HCECs were treated with differ...
<p>(a) Ang II infusion increased cardiac NF-κB p65 activity in WT mice but not in TNF-α<sup>-/-</sup...
<p>Western blot of phosphorylated (p) and total JNK, p38 MAPK (<b>A</b>), and NF-κB p65 (<b>B</b>). ...
<p>Ha-ANNEXIN can suppress MKK1 (A)—or NPK1<sup>Nt</sup> (B)-triggered cell death. Results of the ve...
<p>Western blot analysis of p38/MAPK phosphorylation in MCF-7 cells treated with vehicle (0), E2 (pa...
<p>(A) Kinetics of IκBα degradation and increase in phosphorylation of p65 at serine 536. After veh,...
<p>(A) IκBα phosphorylation over time in VAT. VAT was cultured with AngII (1 μM) for the indicated t...
<p>(<b>A</b>) Expression of different angiogenic factors (left panel) in the vehicle- and PTK787 tre...
<p>A,.Western blotting of Bax and Bcl-2 in the mitochondrial fraction and cytosolic fraction of NRK-...
Western blot analyses showing quantification of phosphorylated levels of p38 and ERK1/2. Total level...
<p>(A) Negative control and the immunocytochemical staining of EL at 0 h, 4 h, 8 h, 12 h and 24 h af...
<p>Panel A: The p38<sup>MAPK</sup> inhibitor SB203580 (10 µM) reversed the antiproliferative effect ...
<p>A. The cells were incubated with 0, 10, 50, 250, and 1000 ng/ml Ang for 2 h. The proteins of phos...
<p>AngII treatment was shown to promote HUVEC proliferation by immunofluorescence staining of PCNA a...
<p>(A) Representative Western blotting results, showing bands for phosphorylated ERK1/2 (p-ERK1/2) a...
<p>(A) rhGM-CSF induced activation of the p38 MAPK signaling pathway. HCECs were treated with differ...
<p>(a) Ang II infusion increased cardiac NF-κB p65 activity in WT mice but not in TNF-α<sup>-/-</sup...
<p>Western blot of phosphorylated (p) and total JNK, p38 MAPK (<b>A</b>), and NF-κB p65 (<b>B</b>). ...
<p>Ha-ANNEXIN can suppress MKK1 (A)—or NPK1<sup>Nt</sup> (B)-triggered cell death. Results of the ve...
<p>Western blot analysis of p38/MAPK phosphorylation in MCF-7 cells treated with vehicle (0), E2 (pa...
<p>(A) Kinetics of IκBα degradation and increase in phosphorylation of p65 at serine 536. After veh,...
<p>(A) IκBα phosphorylation over time in VAT. VAT was cultured with AngII (1 μM) for the indicated t...
<p>(<b>A</b>) Expression of different angiogenic factors (left panel) in the vehicle- and PTK787 tre...
<p>A,.Western blotting of Bax and Bcl-2 in the mitochondrial fraction and cytosolic fraction of NRK-...
Western blot analyses showing quantification of phosphorylated levels of p38 and ERK1/2. Total level...